Improving the Common Metabolic Diseases Knowledge Portal to better understand type 2 diabetes biology
Augmenting the CMDKP with advanced features for understanding biological mechanisms
This project upgrades an online diabetes data portal so researchers can more quickly connect genetic and biological clues to help people with type 2 diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11327615 on NIH RePORTER |
What this research studies
This project expands the Common Metabolic Diseases Knowledge Portal by bringing together genetic, genomic, and health data related to type 2 diabetes. Researchers will add advanced statistical and AI-based tools to organize results into higher-level biological relationships that are easier to search and interpret. They will update data-processing pipelines and user interfaces so scientists can run complex queries and find genes, pathways, or drug targets linked to diabetes. Most of the work is computational and uses existing human datasets, so patients would not need to visit a study site to contribute through data-sharing efforts.
Who could benefit from this research
Good fit: Adults living with type 2 diabetes or related common metabolic disorders are the population this work focuses on and could benefit from future discoveries.
Not a fit: People with non-metabolic forms of diabetes (for example, type 1 diabetes or rare monogenic diabetes) or those seeking immediate changes to their care are unlikely to see direct benefits from this project.
Why it matters
Potential benefit: If successful, the portal could speed discovery of new drug targets and lead to better prevention or treatments for people with type 2 diabetes.
How similar studies have performed: The CMDKP already exists and is widely used to improve genetic and genomic data access, and these enhancements build on that successful foundation.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Flannick, Jason — Broad Institute, INC.
- Study coordinator: Flannick, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.